News & Analysis as of

Research and Development DEA Cannabis-Related Businesses (CRBs)

Harris Beach Murtha PLLC

Trump May Ease Federal Restrictions by Rescheduling Marijuana

President Trump has indicated he may ease federal restrictions on marijuana, specifically by rescheduling cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). This would be the first move his...more

Gardner Law

FDA's View on Cannabis

Gardner Law on

The U.S. Food and Drug Administration (FDA) is continuing to support clinical research for cannabis and psychedelic drug development. On the heels of publishing its first draft guidance on clinical trials involving...more

Troutman Pepper Locke

HHS Proposes Rescheduling Cannabis to Schedule III – What It Means for the Industry

Troutman Pepper Locke on

It has been widely reported and confirmed publicly that, on August 29, the U.S. Department of Health and Human Services (HHS) sent a letter to the Drug Enforcement Administration (DEA) recommending that cannabis be moved from...more

Seyfarth Shaw LLP

The Week in Weed: March 2020 #4

Seyfarth Shaw LLP on

Let’s start off with the DEA.  On Monday, they released a proposed rule to expand marijuana research.  For the first time, more than one institution would be permitted to register with the agency and grow cannabis.  The...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide